World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
104
Citations
37799
World Ranking
7083
National Ranking
3723

Overview

Robert C. Seeger is affiliated with the Children's Hospital of Los Angeles in the United States. Their research spans multiple fields within medicine and molecular biology with a focus on areas including neurology, oncology, cancer research, molecular biology, and paleontology.

The scientist's work primarily concentrates on neuroblastoma research and treatments, cancer hypoxia and metabolism, lung cancer research, cancer therapeutics and mechanisms, glioma diagnosis and treatment, as well as paleontology and evolutionary biology. These areas reflect a diverse research portfolio with a strong emphasis on cancer and neurological diseases alongside evolutionary studies.

Frequent co-authors collaborating with Robert C. Seeger include Michael J. Zobel, Abigail K. Zamora, Michael A. Sheard, Shahab Asgharzadeh, and Eugene S. Kim. Their partnership appears consistent across multiple projects, highlighting a collaborative approach in their research efforts.

Publications by Robert C. Seeger are found in a variety of scientific journals. The venues include Genome Research, Journal for ImmunoTherapy of Cancer, Frontiers in Ecology and Evolution, Pediatric Blood & Cancer, and Biology of Blood and Marrow Transplantation.

Recent papers illustrate the scope and focus of the scientist's research:

  • Somatic structural variation targets neurodevelopmental genes and identifies SHANK2 as a tumor suppressor in neuroblastoma, 2020, Genome Research
  • Initiation of immunotherapy with activated natural killer cells and anti-GD2 antibody dinutuximab prior to resection of primary neuroblastoma prolongs survival in mice, 2020, Journal for ImmunoTherapy of Cancer
  • Revised Description of the Early Permian Recumbirostran "Microsaur" Nannaroter mckinziei Based on New Fossil Material and Computed Tomographic Data, 2021, Frontiers in Ecology and Evolution
  • Expression of neuroblastoma-related genes in bone marrow at end of high-risk neuroblastoma therapy, 2022, Pediatric Blood & Cancer
  • Significant Targeting of Neuroblastoma By Anti-ROR1 Chimeric Antigen Receptor (CAR) Engineered NK Cells with or without IL-15 Superagonist (N-803) in Vitro and In Vivo Using Human Neuroblastoma Xenografted NSG Mice, 2020, Biology of Blood and Marrow Transplantation

Best Publications

  • Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage

    GM Brodeur;RC Seeger;RC Seeger;M Schwab;HE Varmus

  • Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas.

    Robert C. Seeger;Garrett M. Brodeur;Harland Sather;Andree Dalton

  • Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

    Alice L. Yu;Andrew L. Gilman;M. Fevzi Ozkaynak;Wendy B. London

  • The genetic landscape of high-risk neuroblastoma

    Trevor J Pugh;Olena Morozova;Edward F Attiyeh;Edward F Attiyeh;Shahab Asgharzadeh;Shahab Asgharzadeh

  • Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study

    Katherine K. Matthay;C. Patrick Reynolds;Robert C. Seeger;Hiroyuki Shimada

  • Chromosome 1p and 11q deletions and outcome in neuroblastoma.

    Edward F. Attiyeh;Wendy B. London;Yael P. Mossé;Qun Wang

  • Evidence for an Age Cutoff Greater Than 365 Days for Neuroblastoma Risk Group Stratification in the Children's Oncology Group

    W.B. London;R.P. Castleberry;K.K. Matthay;A.T. Look

  • Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival.

    Steven DuBois;Yan Kalika;John Lukens;Garrett Brodeur

  • Human NKT Cells Mediate Antitumor Cytotoxicity Directly by Recognizing Target Cell CD1d with Bound Ligand or Indirectly by Producing IL-2 to Activate NK Cells

    Leonid S. Metelitsa;Olga V. Naidenko;Anita Kant;Hong-Wei Wu

  • Effects of retinoic acid (RA) on the growth and phenotypic expression of several human neuroblastoma cell lines

    Neil Sidell;Adrienne Altman;Mark R. Haussler;Robert C. Seeger

  • Exosome-Mediated Transfer of microRNAs Within the Tumor Microenvironment and Neuroblastoma Resistance to Chemotherapy

    Kishore B. Challagundla;Petra M. Wise;Paolo Neviani;Haritha Chava

  • ATM is down-regulated by N-Myc–regulated microRNA-421

    Hailiang Hu;Liutao Du;Gindy Nagabayashi;Robert C. Seeger

  • Common variations in BARD1 influence susceptibility to high-risk neuroblastoma

    Mario Capasso;Marcella Devoto;Cuiping Hou;Shahab Asgharzadeh

  • Vα24-invariant NKT cells mediate antitumor activity via killing of tumor-associated macrophages

    Liping Song;Shahab Asgharzadeh;Jill Salo;Kelly Engell

  • Increase of Ceramide and Induction of Mixed Apoptosis/Necrosis by N -(4-Hydroxyphenyl)- retinamide in Neuroblastoma Cell Lines

    Maurer Bj;Metelitsa Ls;Seeger Rc;Cabot Mc

  • Outcome after Reduced Chemotherapy for Intermediate-Risk Neuroblastoma

    David L. Baker;Mary L. Schmidt;Susan L. Cohn;John M. Maris

  • Morphology, Growth, Chromosomal Pattern, and Fibrinolytic Activity of Two New Human Neuroblastoma Cell Lines

    Robert C. Seeger;Sylvia A. Rayner;Ashu Banerjee;Helen Chung

  • Chromosome 6p22 Locus Associated with Clinically Aggressive Neuroblastoma

    John M. Maris;Yael P. Mosse;Jonathan P. Bradfield;Cuiping Hou

  • Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study

    Suzanne S. Shusterman;Wendy B. London;Stephen D. Gillies;Jacquelyn A. Hank

  • Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas.

    Chun Guo;Peter S White;Matthew J Weiss;Michael D Hogarty

Frequent Co-Authors

John M. Maris
John M. Maris Children's Hospital of Philadelphia
Katherine K. Matthay
Katherine K. Matthay University of California, San Francisco
Hiroyuki Shimada
Hiroyuki Shimada Stanford University
Richard Sposto
Richard Sposto University of Southern California
Wendy B. London
Wendy B. London Harvard University
Garrett M. Brodeur
Garrett M. Brodeur Children's Hospital of Philadelphia
C. Patrick Reynolds
C. Patrick Reynolds Texas Tech University Health Sciences Center
Daniel O. Stram
Daniel O. Stram University of Southern California
Susan L. Cohn
Susan L. Cohn University of Chicago
Michael D. Hogarty
Michael D. Hogarty Children's Hospital of Philadelphia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a career in Medicine doesn’t always mean following the traditional MD path. There are numerous related degrees that can help you achieve your professional goals—many of which can be earned online with increased flexibility and affordability.

For those already working in healthcare management, you might explore whats the best online mha program for working adults to boost your leadership and administrative skills without putting your career on hold.

Nurses aiming to advance may be interested in rn bsn online programs no clinicals, offering opportunities to earn a BSN without traditional clinical requirements.

If your goal is to reach the highest level of nursing practice, check out online dnp programs. These doctorate-level degrees can often be completed faster online. For those mindful of cost, there are also cheapest dnp programs available, helping you minimize debt while advancing your credentials.

Exploring these alternative online programs can open new avenues in healthcare, providing modern, practical pathways to rewarding medical careers.

Best Scientists Citing Robert C. Seeger

Trending Scientists